Why FDA Boosters Authorization Could Be More Important for Pfizer and Moderna Than You Might Think

Why FDA Boosters Authorization Could Be More Important for Pfizer and Moderna Than You Might Think

Source: 
Motley Fool
snippet: 
  • Neither Pfizer nor Moderna will make extra revenue from boosters recently authorized by the FDA.
  • The FDA's authorization decision, though, could pave the way for later authorization of annual boosters.
  • Annual boosters are highly important to Pfizer's and Moderna's prospects.